The canine blood-brain barrier in health and disease: focus on brain protection

This review examines the role of the canine blood-brain barrier (BBB) in health and disease, focusing on the impact of the multidrug resistance (MDR) transporter P-glycoprotein (P-gp) encoded by the ABCB1/MDR1 gene. The BBB is critical in maintaining central nervous system homeostasis and brain prot...

Full description

Saved in:
Bibliographic Details
Main Authors: Dimitri Bassalo, Stephen G. Matthews, Enrrico Bloise
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Veterinary Quarterly
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/01652176.2025.2450041
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841550088870035456
author Dimitri Bassalo
Stephen G. Matthews
Enrrico Bloise
author_facet Dimitri Bassalo
Stephen G. Matthews
Enrrico Bloise
author_sort Dimitri Bassalo
collection DOAJ
description This review examines the role of the canine blood-brain barrier (BBB) in health and disease, focusing on the impact of the multidrug resistance (MDR) transporter P-glycoprotein (P-gp) encoded by the ABCB1/MDR1 gene. The BBB is critical in maintaining central nervous system homeostasis and brain protection against xenobiotics and environmental drugs that may be circulating in the blood stream. We revise key anatomical, histological and functional aspects of the canine BBB and examine the role of the ABCB1/MDR1 gene mutation in specific dog breeds that exhibit reduced P-gp activity and disrupted drug brain pharmacokinetics. The review also covers factors that may disrupt the canine BBB, including the actions of aging, canine cognitive dysfunction, epilepsy, inflammation, infection, traumatic brain injury, among others. We highlight the critical importance of this barrier in maintaining central nervous system homeostasis and protecting against xenobiotics and conclude that a number of neurological-related diseases may increase vulnerability of the BBB in the canine species and discuss its profound impacts on canine health.
format Article
id doaj-art-27d2b170fb17453fa7e7bd6de3f64b44
institution Kabale University
issn 0165-2176
1875-5941
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Veterinary Quarterly
spelling doaj-art-27d2b170fb17453fa7e7bd6de3f64b442025-01-10T09:27:35ZengTaylor & Francis GroupVeterinary Quarterly0165-21761875-59412025-12-01451123210.1080/01652176.2025.2450041The canine blood-brain barrier in health and disease: focus on brain protectionDimitri Bassalo0Stephen G. Matthews1Enrrico Bloise2Especialização em Farmacologia, Departamento de Farmacologia, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilDepartment of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, CanadaDepartment of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, CanadaThis review examines the role of the canine blood-brain barrier (BBB) in health and disease, focusing on the impact of the multidrug resistance (MDR) transporter P-glycoprotein (P-gp) encoded by the ABCB1/MDR1 gene. The BBB is critical in maintaining central nervous system homeostasis and brain protection against xenobiotics and environmental drugs that may be circulating in the blood stream. We revise key anatomical, histological and functional aspects of the canine BBB and examine the role of the ABCB1/MDR1 gene mutation in specific dog breeds that exhibit reduced P-gp activity and disrupted drug brain pharmacokinetics. The review also covers factors that may disrupt the canine BBB, including the actions of aging, canine cognitive dysfunction, epilepsy, inflammation, infection, traumatic brain injury, among others. We highlight the critical importance of this barrier in maintaining central nervous system homeostasis and protecting against xenobiotics and conclude that a number of neurological-related diseases may increase vulnerability of the BBB in the canine species and discuss its profound impacts on canine health.https://www.tandfonline.com/doi/10.1080/01652176.2025.2450041P-glycoprotein (P-gp/ABCB1/MDR1)brain endothelial cells (BECs)infectionagingepilepsytraumatic brain injury (TBI)
spellingShingle Dimitri Bassalo
Stephen G. Matthews
Enrrico Bloise
The canine blood-brain barrier in health and disease: focus on brain protection
Veterinary Quarterly
P-glycoprotein (P-gp/ABCB1/MDR1)
brain endothelial cells (BECs)
infection
aging
epilepsy
traumatic brain injury (TBI)
title The canine blood-brain barrier in health and disease: focus on brain protection
title_full The canine blood-brain barrier in health and disease: focus on brain protection
title_fullStr The canine blood-brain barrier in health and disease: focus on brain protection
title_full_unstemmed The canine blood-brain barrier in health and disease: focus on brain protection
title_short The canine blood-brain barrier in health and disease: focus on brain protection
title_sort canine blood brain barrier in health and disease focus on brain protection
topic P-glycoprotein (P-gp/ABCB1/MDR1)
brain endothelial cells (BECs)
infection
aging
epilepsy
traumatic brain injury (TBI)
url https://www.tandfonline.com/doi/10.1080/01652176.2025.2450041
work_keys_str_mv AT dimitribassalo thecaninebloodbrainbarrierinhealthanddiseasefocusonbrainprotection
AT stephengmatthews thecaninebloodbrainbarrierinhealthanddiseasefocusonbrainprotection
AT enrricobloise thecaninebloodbrainbarrierinhealthanddiseasefocusonbrainprotection
AT dimitribassalo caninebloodbrainbarrierinhealthanddiseasefocusonbrainprotection
AT stephengmatthews caninebloodbrainbarrierinhealthanddiseasefocusonbrainprotection
AT enrricobloise caninebloodbrainbarrierinhealthanddiseasefocusonbrainprotection